| Income Statement |
| Operating Expenses | 3.03M |
|
| Research and Development Expense | 1.09M |
| Selling, General and Administrative Expense | 1.94M |
| Operating Income | -3.03M |
| Interest Expense | 2.01K |
| Net Income | -3.03M |
| Net Income Common Stock | -3.03M |
| Net Income Common Stock (USD) | -3.03M |
| Consolidated Income | -3.03M |
| Earnings per Basic Share | -0.68 |
| Earnings per Basic Share (USD) | -0.68 |
| Earnings per Diluted Share | -0.68 |
| Earning Before Interest & Taxes (EBIT) | -3.02M |
| Earning Before Interest & Taxes (USD) | -3.02M |
| Weighted Average Shares | 4.48M |
| Weighted Average Shares Diluted | 4.48M |
| Balance Sheet |
| Cash and Equivalents | 7.59M |
| Cash and Equivalents (USD) | 7.59M |
| Current Assets | 8.25M |
| Property, Plant & Equipment Net | 287.18K |
| Total Assets | 8.54M |
| Current Liabilities | 2.74M |
| Total Liabilities | 2.74M |
| Accumulated Retained Earnings (Deficit) | -70.33M |
| Shareholders Equity | 5.80M |
| Shareholders Equity (USD) | 5.80M |
| Assets Non-Current | 287.18K |
| Trade and Non-Trade Payables | 2.74M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 27.69K |
| Net Cash Flow from Financing | 8.02M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.88M |
| Issuance (Purchase) of Equity Shares | 669.27K |
| Net Cash Flow from Operations | -1.14M |
| Share Based Compensation | 77.20K |